InVivo Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $10,650,000.
Profit Margin
| 2013 | 0 | -38.75M | |
|---|---|---|---|
| 2014 | 0 | -18.34M | |
| 2015 | 0 | -33.31M | |
| 2016 | 0 | -23.43M | |
| 2017 | 0 | -26.74M | |
| 2018 | 0 | -46.24M | |
| 2019 | 0 | -12.24M | |
| 2020 | 0 | -9.05M | |
| 2021 | 0 | -9.89M | |
| 2022 | 0 | -10.17M |
NVIV Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 445K | 372K | 329K | 322K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | -445K | -372K | -329K | -322K | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 5.22M | 4.38M | 3.93M | 5.60M | 4.93M | 11.08M | 12.55M | 10.05M | 10.27M | 10.53M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 10.65M | 9.9M | 9.09M | 11.49M | 12.76M | 24.59M | 24.06M | 22.39M | 17.83M | 19.00M |
Operating income | -10.65M | -9.9M | -9.09M | -11.49M | -12.76M | -24.59M | -24.06M | -22.39M | -17.83M | -19.00M |
Other income (expenses), net | 160K | 5K | 23K | -333K | -10.65M | -3.05M | 593K | -10.91M | -507K | -19.63M |
Income before tax | -10.49M | -9.89M | -9.07M | -11.83M | -23.42M | -26.74M | -23.43M | -33.31M | -18.34M | -38.75M |
Income tax expense | -311K | -3K | -19K | 412K | 22.82M | 2.26M | -593K | 10.80M | 376K | 19.63M |
Net income | -10.17M | -9.89M | -9.05M | -12.24M | -46.24M | -26.74M | -23.43M | -33.31M | -18.34M | -38.75M |
Earnings per share | ||||||||||
Basic EPS | -6.62 | -7.47 | -32.8 | -912.63 | -6.95K | -15.22K | -14.17K | -23.61K | -15.58K | -36.91K |
Diluted EPS | -6.62 | -7.47 | -32.8 | -912.63 | -6.95K | -15.22K | -14.17K | -23.61K | -15.58K | -36.91K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |